Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alchemab Therapeutics
Biotech
Alchemab CEO resigns citing 'personal reasons'—Chutes & Ladders
Alchemab CEO suddenly resigns. Infant biotech Civeta builds out scientific leadership. Rajangam jumps from Nkarta to Senti Bio.
Max Bayer
May 27, 2022 9:30am
Lightstone raises $375M for third fund after 3 big exits in 2020
Sep 14, 2021 10:05am
Alchemab picks up new well-connected CEO
Jun 22, 2021 10:25am
AstraZeneca taps antibody miner Alchemab for prostate R&D deal
May 5, 2021 10:25am